Wound Care Biologics Market Size By Product (Skin Substitutes {Biological [Allograft, Xenograft], Synthetic}, Topical Agents), By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Surgical Wounds, Burns), By End-Use (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, UAE, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jan 2019 | 120 Pages | Report ID: GMI2925 | Authors: Sumant Ugalmugale, Shradha Mupid Report Format: PDF

  Request Sample Inquiry Before Buying
Summary Table of Contents Industry Coverage Methodology Request for Customization

Industry Trends

Wound care biologics market size was valued over USD 1.4 billion in 2018 and is expected to witness 9.5% CAGR from 2019 to 2025.
 

U.S. Wound Care Biologics Market Size, By Product, 2018 & 2025 (USD Million)
U.S. Wound Care Biologics Market Size, By Product, 2018 & 2025 (USD Million)

Get more details on this report by requesting a free sample copy
 

Rising incidences of burn injuries specifically in developing and underdeveloped countries will positively impact the wound care biologics industry growth during the forecast period. Countries such as Africa and Brazil have high number of burn cases. For instance, according to WHO, around 180,000 deaths are caused due to burns in low- and middle-income countries annually. Burns not only have high economic impact but also has disastrous effects on the victim’s skin. Burns are classified depending upon the severity of injury, several treatment options are available. Wound care biologics is one of the widely preferred treatments in case of burns as it enables fast recovery with minimum or no complications. Therefore, availability of superior quality synthetic substitutes and it’s growing demand in treatment of burns has proven beneficial for the industry growth.
 

Innovations in the wound care biologics will foster the industry growth in upcoming years. Key industry players operational in the wound care biologics industry spends rigorously on R&D to develop quality wound care biologics products. For instance, xenografts offered by the companies can introduce collagen in the wounds that enables dermal regeneration. The exogenous collagen provides three-dimensional structure for the tissue growth and these xenografts are absorbed after the wound has completely healed. Also, skin substitutes recently developed are extensively utilized for treating post-surgical wounds. Therefore, availability of superior quality wound care biologics will boost the industry growth in foreseeable future. However, high cost of the wound care biologic products may restrain the industry growth to some extent.
 

Wound Care Biologics Market, By Product

Skin substitutes segment was valued at USD 940.6 million in 2018. Bioengineered skin and substitutes demand in surgeries has been growing in recent years. Also, recent advancements in skin tissue engineering have elevated its adoption amongst the doctors performing surgical procedures escalating the segmental growth. Bioengineered skin and substitute are one of the useful tools in reconstructive surgery practices prominently used as an alternative to skin grafts. For instance, allogenic acellular dermal matrix has high preference in the breast reconstruction procedures. Also, acellular dermal matrix products are utilized in diabetic-lower extremity ulcers. High usage of such superior bioengineered skin and soft in aesthetic procedures will drive the segmental growth during the forecast period.
 

Topical agents’ segment will experience 8.9% CAGR during the forecast timeframe. Increasing demand for skin reconstruction and other aesthetic surgeries will drive the demand for topical agents. Phases of tissue repair are generally controlled by active topical agents. Also, topical agents have a vital role in tissue bio-engineering and are extensively preferred during the trauma cases that positively impacts the segmental growth.
 

Wound Care Biologics Market, By Wound Type

Diabetic foot ulcers segment accounted for 16.8% in 2018 and is expected to show similar growth trends over the upcoming years. Diabetic wounds are caused due to high sugar levels that usually lead to hormonal imbalance and give rise to diseases such as chronic foot ulcers. As reported by OxyGeneration, of the total people suffering from diabetes at least 15%-20% will suffer from foot ulcers. Generally, clinicians prefer wound care biologics that provides moist environment for wound healing. Therefore, high usage of wound care biologics in treatment of diabetic wounds will augment the segmental growth.
 

Pressure ulcer segment will experience 10.2% CAGR during the forecast timeframe. Increasing prevalence of pressure wounds such as bed sores will positively impact the demand for wound care biologics. Patients struggling with chronic diseases such as diabetes often have slower healing rates and are prone to bed sores. Also, patients with bone disorders are bed ridden and often suffer from bed sores. Moreover, pressure ulcers include serious complications such as cellulites bacteremia sepsis and septic arthritis that further stimulates the demand for wound care biologics escalating the segmental growth.
 

Germany Wound Care Biologics Market Size, By Wound Type, 2018 (USD Million)
 Germany Wound Care Biologics Market Size, By Wound Type, 2018 (USD Million)

Get more details on this report by requesting a free sample copy
 

Wound Care Biologics Market, By End-use

Hospitals segment was valued at USD 665.5 million in 2018 and is expected to have substantial revenue size during the forecast timeframe. Significant revenue size can be attributed to the increasing use of wound care biologics in treating patients suffering from diabetic foot ulcers, pressure ulcers and skin burns. Moreover, high usage of allografts and other skin substitutes in the treatment of post-surgical wounds will flourish the segmental growth in forthcoming years.
 

Ambulatory surgical centers segment accounted for 31.5% revenue share in 2018. Ambulatory surgical centres can offer lower-priced procedures as they have a lower cost structure compared to traditional hospital setting. Though the cost structures are low, the operational efficiencies are uncompromised that increases their preference. Moreover, ASCs are generally located in the suburbs and rural areas that provides patients with better access that should positively impact the segmental growth.
 

Wound Care Biologics Market, By Region

U.S. wound care biologics market will experience 8.8% CAGR and is expected to grow substantially during the forecast timeframe. High growth can be attributed to the increasing perveance of diabetic foot ulcers. According to Azura Vascular Care, around 10% of people suffering from diabetes acquire chronic foot ulcers. Wound healing process is slow in patients with diabetes as the oxygen doesn’t reach most of the cells in the body that increases the chances of susceptibility for microbial and fungal skin infections. Moreover, growing preference for skin substitutes in aesthetic surgeries will augment the U.S. wound care biologics market growth during forecast timeframe.
 

India wound care biologics market was valued at USD 55.3 million in 2018. Growing number of burn cases will favor the India wound care biologics market growth. Third-degree burns are generally treated with skin grafts and bio-engineered skin tissues that enables quicker recovery. Moreover, growing geriatric population will positively impact the industry growth over forthcoming years.

 

Asia Pacific Wound Care Biologics Market Size, By Country, 2025 (USD Million)
Asia Pacific Wound Care Biologics Market Size, By Country, 2025 (USD Million)

Get more details on this report by requesting a free sample copy

 

Competitive Market Share

Key industry players operational in wound care biologics market includes Smith & Nephew, Integra Life Sciences, Mölnlycke Health Care AB, Mimedx Group, Wright Medical, Osiris Therapeutics, Derma Sciences, Kerecis, Amnio Technology, Solsys Medica and Skye Biologics. These key industry players implement strategies such as new product launches, mergers, acquisitions and collaborations to sustain in market competition. For instance, in April 2017, Skye Biologics & Human Regenerative Technologies launched BioECM membrane that has surgeries wound healing applications. Launch of new products will foster company’s revenue generation.
 

Wound Care biologics Industry Background
 

Wound Care Biologics Market Segmentation
Get more details on this report by requesting a free sample copy
 

Wound care biologics industry evolution can be traced back to 1793 that marked the usage of cotton gin in wound management. Since then, the wound care biologics industry has experienced significant evolution. Anti-septic dressings later replaced the conventional dressings available as the antiseptic dressings provided faster wound healing with minimum microbial activity. Currently, with progress in research and studies, wound care biologics such as biotechnologically engineered skin and topical agents have transformed the wound healing process making it easier and convenient. Also, key industry players create differentiation in the product offerings that creates numerous growth opportunities.
 


What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree